About TFF Pharmaceuticals
TFF Pharmaceuticals is a company based in Austin (United States) founded in 2018. TFF Pharmaceuticals has raised $22.17 million across 5 funding rounds from investors including HHS, NIAID and Liquid Venture Partners. The company has 15 employees as of December 31, 2022. TFF Pharmaceuticals offers products and services including Biopharmaceutical Drugs. TFF Pharmaceuticals operates in a competitive market with competitors including MediciNova, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others.
- Headquarter Austin, United States
- Employees 15 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Tff Pharmaceuticals, Inc.
-
Annual Revenue
$733.87 K (USD)48as on Dec 31, 2023
-
Net Profit
-$21.24 M (USD)33as on Dec 31, 2023
-
EBITDA
-$21.89 M (USD)31as on Dec 31, 2023
-
Total Equity Funding
$22.17 M (USD)
in 5 rounds
-
Latest Funding Round
$864.95 K (USD), Grant
Jul 03, 2023
-
Investors
HHS
& 2 more
-
Employee Count
15
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TFF Pharmaceuticals
TFF Pharmaceuticals offers a comprehensive portfolio of products and services, including Biopharmaceutical Drugs.
Focuses on clinical stage pharmaceutical innovations for research purposes
People of TFF Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of TFF Pharmaceuticals
TFF Pharmaceuticals has successfully raised a total of $22.17M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $864.95 thousand completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TFF Pharmaceuticals
TFF Pharmaceuticals has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, NIAID and Liquid Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Liquid Venture Partners is engaged in assisting young companies with transformative technologies to go public through Nasdaq IPOs.
|
Locked | Locked | Locked |
Investor details for TFF Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TFF Pharmaceuticals
Investment portfolio details for TFF Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TFF Pharmaceuticals
Detailed financials for TFF Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tff Pharmaceuticals Comparisons
Peer comparison for TFF Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TFF Pharmaceuticals
TFF Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| Locked | Locked | Locked |
Inhalation therapies for pulmonology disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
Detailed competitors of TFF Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tff Pharmaceuticals
Complete news archive for TFF Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TFF Pharmaceuticals
TFF Pharmaceuticals was founded in 2018.
TFF Pharmaceuticals is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Harlan Weisman is the current CEO of TFF Pharmaceuticals.
TFF Pharmaceuticals is a funded company, having raised a total of $22.17M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at TFF Pharmaceuticals is 15.
Annual revenue of TFF Pharmaceuticals is $733.87K as on Dec 31, 2023.
TFF Pharmaceuticals was founded in 2018 in Austin, United States, focusing on the pharmaceutical sector. Proprietary thin-film freezing technology is employed to produce dry powder inhalers for respiratory drugs. This approach is applied to small molecules, biologics, and combination therapies targeting chronic respiratory conditions. Operations center on advancing inhalation delivery systems for improved drug administration.
TFF Pharmaceuticals's top competitors include Theravance Biopharma, MediciNova and ReAlta Life Sciences.
TFF Pharmaceuticals offers Biopharmaceutical Drugs.
TFF Pharmaceuticals has 3 investors. Key investors include HHS, NIAID, and Liquid Venture Partners.